Radar · Life Sciences in Raleigh
Best Life Sciences Companies in Raleigh, United States
The 87 best Life Sciences companies in Raleigh, United States in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: Sprout Pharmaceuticals.
By Rohit KhannaTrends & Stories
87companies tracked
$1.1Bdisclosed funding
0unicorns
45have raised
FLIAR INTELLIGENCE · LIFE SCIENCES × RALEIGH
Our analysis of 164 Life Sciences companies
$34.7b in tracked funding; 83% of the stack-profiled cohort runs cloud-native; funding activity peaked in 2025.
164companies analysed
83%cloud-native stacks
2025funding peak (by rounds)
7unicorns
2016median founding year
Ranked: Best Life Sciences companies in Raleigh
| # | Company | Disclosed funding | Last round | Employees | Founded | Founder | Tech stack | Patents & IP focus | Recent signals |
|---|---|---|---|---|---|---|---|---|---|
| 1 | Sprout Pharmaceuticals Developer of drugs for hypoactive sexual desire disorder in women | $175M | 18 mo ago | 31 | 2011 | — | Cart FunctionalitySquarespace CommerceSquarespace+15 | — | — |
| 2 | Micell Drug eluting coronary stent | $158M | 105 mo ago | 2 | 1995 | — | — | 363 patents Controlled-release polymer coatings for drug-eluting, bioabsorbable medical implants and devices | — |
| 3 | Slate Medicines Developer of therapeutics for the treatment of migraine and other headache disorders 53Funding top 20%Talent bottom 49%Global bottom 48% All 3 signals ▾Fundingtop 20% Talentbottom 49% Globalbottom 48% Funding: Raised $130M across 1 rounds · 1 rounds over 1 yrs (1.0/yr) Talent: 1 named leader on record · 1 C-suite/founder profile curated rank vs industry peers · Fliar Intelligence Index 53/100 | $130M | 4 mo ago | — | 2026 | Neil Buckley Co-Founder & CEO | — | — | — |
| 4 | Bryn Pharma Developer of nasal based epinephrine for anaphylaxis 10Funding top 26%Talent bottom 49%Global bottom 29%News bottom 24% All 6 signals ▾Fundingtop 26% Talentbottom 49% Globalbottom 29% Newsbottom 24% Marketbottom 20% Techbottom 17% Funding: Raised $123M across 6 rounds · 6 rounds over 8 yrs (0.8/yr) Talent: 1 named leader on record · 1 C-suite/founder profile curated rank vs industry peers · Fliar Intelligence Index 10/100 | $123M | 14 mo ago | 10 | 2018 | David Dworaczyk Retired CEO: Corporate Advisor/Consultant to Bryn Pharma | PleskWindows ServerMicrosoft ASP.NET+10 | — | — |
| 5 | Locus Biosciences Developer of therapeutics for infectious disease and inflammatory indications | $67M | 28 mo ago | 74 74 → 61 (-18%) | 2015 | Paul Garofolo Chief Executive Officer | WordPress Block EditorWordPressMySQL+24 | 60 patents Engineered CRISPR‑enhanced bacteriophage therapeutics targeting antibiotic‑resistant bacterial infections | — |
| 6 | Contego Medical Provider of vascular stenting with embolic protection for both coronary and peripheral vasculature | $66M | 38 mo ago | 33 | 2005 | — | — | — | — |
| 7 | Ribometrix Provider RNA-targeted drug discovery platform | $65M | 80 mo ago | 26 | 2016 | — | — | 9 patents eIF4E inhibitor small molecules for oncology therapeutics | — |
| 8 | BioDelivery Sciences International Specialty pharmaceutical solutions for pain management and addiction | $40M | 84 mo ago | 188 | 1997 | Jeffrey Bailey CEO | — | 204 patents Mucoadhesive, abuse‑resistant transmucosal drug delivery systems for opioids and pain therapeutics. | — |
| 9 | Valencell Developer of based medical sensors for monitoring body vitals | $38M | 76 mo ago | 34 | 2006 | Steven Leboeuf President & Co-Founder | Tailwind CSSVue.jsAstro+13 | 418 patents Wearable photoplethysmography sensors for real-time health metrics estimation | — |
| 10 | Aer Therapeutics Developing an inhaled approach to treat lung disease with excess mucus and mucus plugs | $36M | 16 mo ago | 8 | 2014 | John Fahy Founder | — | — | — |
| 11 | Marius Pharmaceuticals Developer of an proprietary oral testosterone replacement therapy platform | $33M | 56 mo ago | 20 | 2017 | Himanshu Shah Co-Founder | WordPressMySQLPHP+17 | — | 1 partnership |
| 12 | Glycan Therapeutics Developer of glycan-based therapeutics for coagulation and thrombo inflammation | $23M | 14 mo ago | 4 | 2013 | Yongmei Xu Co-Founder
| TypeScriptBootstrapZone.js+9 | — | — |
| 13 | 9 Meters Biopharma Developer of drug compounds to treat short bowel syndrome and celiac disease | $23M | 73 mo ago | 21 | 2012 | — | WordPress Block EditorWordPressMySQL+37 | 43 patents Therapeutics targeting intestinal tight junctions and barrier permeability for GI disorders. | — |
| 14 | Midatech Developer of therapies focused on oncology treatment and oncology supportive care | $17M | 148 mo ago | — | 2003 | Christopher Clement President and CEO | — | 23 patents Nanoparticle-based peptide drug and vaccine delivery systems for targeted therapeutic administration | — |
| 15 | Clinverse Cloud-based financial lifecycle system for automating clinical payments for the clinical trials industry. | $16M | 142 mo ago | 51 | 2008 | — | — | 4 patents Healthcare payment network for clinical services and billing integration | — |
| 16 | NuPulseCV Transforming chronic heart failure treatment with minimally invasive cardiac assist devices | $14M | 59 mo ago | 23 23 → 20 (-13%) | 2011 | Douglas Altschuler Founder & CEO | — | 81 patents Percutaneous mechanical circulatory support devices and real-time cardiac rhythm monitoring | — |
| 17 | TranS1 Medical device company delivering innovative spine surgery solutions | $12M | 277 mo ago | 32 | 2002 | — | — | 207 patents Spinal minimally invasive surgical tools, implants, and therapeutic devices for vertebral fixation and motion preservation. | — |
| 18 | Clinetic Provider of data analysis and diagnostic tools for clinical trial professionals | $11M | 34 mo ago | 17 | 2017 | Erich Huang Md Founder | — | — | — |
| 19 | Advanced Chemotherapy Technologies Developer of a medical device used for chemotherapy | $8M | 58 mo ago | 12 | 2014 | — | — | — | — |
| 20 | Gentris A provider of pharmacogenomic testing and biorepository services | $6M | 253 mo ago | 40 | 2001 | — | — | 2 patents Generating reference controls for pharmacogenomic testing | — |
| 21 | Altopa Provider of personalized supplements based on a quiz | $5M | 89 mo ago | — | 2016 | Matt Wilson Co-Founder | — | 28 patents Microfluidic precision dispensing and on-demand mixing for personalized formulation delivery | — |
| 22 | EternaTear Developer of medicine for dry eye disease | $5M | 69 mo ago | 2 | 2018 | Tim Willis Founder & CEO | — | 17 patents Eye‑drop pharmaceutical compositions for treating ocular surface disorders. | — |
| 23 | NephroGenex Innovator developing drugs for kidney disease, particularly diabetic nephropathy | $4M | 127 mo ago | 6 | 2004 | — | — | 22 patents Pyridoxamine-based inhibitors targeting advanced glycation end‑products for diabetic nephropathy therapy | — |
| 24 | SelSym Developer of therapeutics for hemostasis and wound healing | $3M | 9 mo ago | 5 | 2019 | — | — | — | — |
| 25 | Bedrock Therapeutics Developer of gene therapy using AAV capsids and immune modulators | $2M | 15 mo ago | — | 2019 | Bedrock Inc Owner | — | — | — |
| 26 | Agile Sciences Develops anti-bacterial small molecules | $2M | 72 mo ago | 11 | 2007 | — | — | — | — |
| 27 | Phitonex Innovative flow cytometry solutions with NovaFluor dyes and conjugated antibodies | $2M | 80 mo ago | 11 | 2017 | Chris Dwyer Co-Founder & CSO | — | 17 patents Nucleic‑acid bioconjugates enabling multiplexed single‑cell assays and signal amplification | — |
| 28 | Benanova Sustainable materials company creating nature-inspired colloid solutions for diverse markets | $2M | 23 mo ago | — | 2013 | Alexander Richter Co-Founder | — | 8 patents Patents concentrated in health & consumer products | — |
| 29 | Flag Therapeutics Developer of small molecule therapeutics for difficult-to-treat cancers | $2M | 83 mo ago | 2 | 2013 | Frank Sorgi President & CEO | — | — | — |
| 30 | LigaTrap Technologies Innovating bioprocess purification technologies for complex biologics and advanced therapies | $2M | 100 mo ago | 9 | 2015 | — | — | — | 2 partnerships |
| 31 | Quadvantage Developer of medical devices for orthopedic surgery | $1M | 32 mo ago | 2 | 2020 | Tom Gutierrez CEO | — | — | — |
| 32 | GeneVentiv Therapeutics Developer of therapeutic solutions for the treatment of hematology disorders | $1M | 13 mo ago | 2 | 2020 | Damon Race CEO & President | — | — | — |
| 33 | Genoverde Provider of genetically engineering plants for higher carbon sequestration | $1M | 93 mo ago | — | 2015 | Samuel Hazen Co-Founder & CSO | — | — | — |
| 34 | Xanofi Nano-fibres for healthcare applications | $825K | 169 mo ago | 9 | 2010 | Miles Wright CEO & Board of Directors | — | 8 patents Nanofiber-based substrates and coatings for enhanced cell culture, hydrophobic surfaces, and dispersion technologies. | — |
| 35 | Vogenx Developer of therapeutics for the treatment of serious metabolic and gastrointestinal diseases | $750K | 6 mo ago | — | 2020 | James Green Chief Executive Officer | — | 9 patents Patents concentrated in health & consumer products | — |
| 36 | Impulse Wellness Developer of wearable sensor technology for physiological data and health insights | $675K | 36 mo ago | — | 2023 | Brady Adcock Co-Founder & Chief Technology Officer | — | 3 patents Personalized wearable biosignal monitoring devices for therapeutic feedback | — |
| 37 | Sapere Bio Diagnostic company that develops non-invasive biomarker tests to measure cellular aging and predict the risk… | $500K | 23 mo ago | 5 | 2013 | Norman Sharpless Co-Founder | — | — | — |
| 38 | Acorn Applications Cloud-Based Analytic Clinical Research Solutions | $500K | 132 mo ago | — | 2013 | Gordon Jones Founder & CEO | — | — | — |
| 39 | Novocor Nervous system regulation through data-driven somatic exercises and evidence-based practices | $337K | 134 mo ago | — | 2013 | Tony Voiers Co-Founder & CEO | — | — | — |
| 40 | BreStem Developer of stem cell and exosome therapies for the treatment of chronic lung diseases | $300K | 59 mo ago | 2 | 2017 | Ke Cheng Founder | — | — | — |
| 41 | MAA Laboratories Transforming molecules into next-generation therapies through advanced nanoparticle technology | $225K | 108 mo ago | 16 | 2013 | Anjani Jha CEO & President | — | — | — |
| 42 | BrainTrip Manufacturer of a wearable device for detecting behavioral changes | $215K | 73 mo ago | 10 | 2017 | Maximiliano Romero CEO | Framer SitesReactLenis+6 | — | — |
| 43 | Avana Health Developer of treatments for women health | $128K | 8 mo ago | 6 | 2021 | Peter Pacult Co-Founder & CEO | Cart FunctionalitySquarespace CommerceSquarespace+10 | — | — |
| 44 | NanoVector Biologic nanoparticle-based therapeutic drug delivery system | $125K | 204 mo ago | — | 2007 | Albert Bender CEO | — | 2 patents Engineering viral vectors for gene delivery and therapeutic applications | — |
Top 12 Life Sciences companies in Raleigh
#1
Series A · Raleigh, North Carolina · founded 2026$130Mraised▾
Series A · Raleigh, North Carolina · founded 2026
Developer of therapeutics for the treatment of migraine and other headache disorders. The company is focused on developing next generation therapeutics targeting PACAP for the treatment and prevention of migraine and other headache disorder
Fliar Intelligence Index™ 53how this company ranks against its industry peers
Funding
top 20%Talent
bottom 49%Global
bottom 48%Funding: Raised $130M across 1 rounds · 1 rounds over 1 yrs (1.0/yr) · Last round Series A (Feb 2026)
Talent: 1 named leader on record · 1 C-suite/founder profile curated
Global: Investors from 1 country beyond United States
Audience (LinkedIn): 1k LinkedIn followers — 3.7% of this cohort's audience
Funding rounds
- Feb 2026Series A$130M
Founders & team
Investors
RA Capital Management, Forbion, Foresite Capital
#2
Series C · Raleigh, North Carolina · founded 2018 · 10 employees$123Mraised▾
Series C · Raleigh, North Carolina · founded 2018 · 10 employees
Bryn Pharma has developed nasal based epinephrine for anaphylaxis. The company has developed a portable epinephrine auto-injector that can also be used as an intranasal epinephrine delivery system to treat allergic reactions or an anaphylactic reaction.
Fliar Intelligence Index™ 10how this company ranks against its industry peers
Funding
top 26%Talent
bottom 49%Global
bottom 29%News
bottom 24%Market
bottom 20%Tech
bottom 17%Funding: Raised $123M across 6 rounds · 6 rounds over 8 yrs (0.8/yr) · Last round Series C (Apr 2025)
Talent: 1 named leader on record · 1 C-suite/founder profile curated
Global: Single-market focus (United States)
Funding rounds
- Apr 2025Series C$4.7M
- Jul 2023Series C$26.7M
- Oct 2022Series C$43.5M
- Jun 2020Series B$26M
Founders & team
Investors
RezVen Partners, Soundproof Ventures, Chazen Capital Partners, Jenkins Fund, AllerFund
#3
Acquired · Raleigh, North Carolina · founded 2011 · 31 employees$174.6Mraised▾
Acquired · Raleigh, North Carolina · founded 2011 · 31 employees
Sprout Pharmaceuticals has developed drugs for women's health. The company has developed an FDA-approved non-hormonal pill called ADDYI to cure Hypoactive Sexual Desire Disorder (HSDD) in premenopausal women.
Funding rounds
- Dec 2024Series D$10.6M
- Apr 2023Series D$7.1M
- Aug 2022Series D$28M
- May 2022Series D$25.1M
Investors
New Ventures Funds, Lunsford Capital, Scientia Ventures
Tech stack
AngularCart FunctionalityCore-JsGodaddyGoogle AnalyticsGoogle Font Api
#4
Funding Raised · Raleigh, North Carolina · founded 2013 · 4 employees$23.3Mraised▾
Funding Raised · Raleigh, North Carolina · founded 2013 · 4 employees
Developer of glycan-based therapeutics for coagulation and thrombo inflammation.The company is developing drug therapies based on a novel synthetic carbohydrate technology platform. The platform technology can be used to synthesize an anticoagulant drug, like synthetic heparin, as well as design heparin-like oligosaccharides for research and development for other medical applications.
Funding rounds
- Apr 2025Grant (prize money)$454.7K
- Apr 2025Grant (prize money)$2.4M
- Sep 2023Grant (prize money)$1.3M
- Sep 2023Grant (prize money)$347.5K
Founders & team
Investors
HHS
Tech stack
AngularApache Http ServerBootstrapCore-JsFont AwesomeGodaddy
#5
Series A · Raleigh, North Carolina · founded 2014 · 8 employees$36Mraised▾
Series A · Raleigh, North Carolina · founded 2014 · 8 employees
Developing an inhaled approach to treat lung disease with excess mucus and mucus plugs. It offers AER-01 a thiol-modified carbohydrate which cleaves mucin disulfide bridges to liquefy mucus plugs and treat muco-obstructive lung diseases.
LinkedIn Pulse recent public activity · Jul 2026
Audience: 1k LinkedIn followers — 4.4% of this cohort's audience
Funding rounds
- Jan 2025Series A$5M
- Dec 2022Series A$36M
Founders & team
Investors
Canaan, Orbimed, Hatteras Venture Partners
#6
Funding Raised · Raleigh, North Carolina · founded 2019 · 5 employees$2.8Mraised▾
Funding Raised · Raleigh, North Carolina · founded 2019 · 5 employees
Developer of therapeutics for hemostasis and wound healing. It offers platelet-mimetic therapeutics for the treatment of uncontrolled bleeding.
LinkedIn Pulse recent public activity · Jul 2026
Audience: 602 LinkedIn followers — 2.2% of this cohort's audience
Funding rounds
- Aug 2025Grant (prize money)$2M
- Sep 2022Grant (prize money)$229.5K
- Jun 2022Conventional Debt$100K
- Mar 2022Grant (prize money)$258.5K
Investors
NCBiotech, HHS, Military Health
#7
Funding Raised · Raleigh, North Carolina · founded 2020$750Kraised▾
Funding Raised · Raleigh, North Carolina · founded 2020
Developer of therapeutics for the treatment of serious metabolic and gastrointestinal diseases. The company's product line include Mizagliflozin which is a small molecule inhibitor of sodium glucose transporter 1 (SGLT1) which act on intestinal lumen for the treatment of post bariatric hypoglycemia.
Funding rounds
- Dec 2025Conventional Debt$750K
Founders & team
#8
Series B · Raleigh, North Carolina · founded 2015 · 74 employees$67.3Mraised▾
Series B · Raleigh, North Carolina · founded 2015 · 74 employees
Developer of therapeutics for infectious disease and inflammatory indications. The company has developed a platform to design and deliver custom CRISPR-Cas systems directly to specific bacteria and enables the development of antimicrobials for infectious diseases.
LinkedIn Pulse recent public activity · Jul 2026
Audience: 9k LinkedIn followers — 32.5% of this cohort's audience
Activity: 1 partnerships (incl. Viatris) announced in 12 mo
Funding rounds
- Jan 2024Grant (prize money)$23.9M
- May 2022Series B$35M
- Oct 2021Conventional Debt—
- Nov 2020Conventional Debt$20M
Founders & team
Investors
Hercules Capital, Tencent, Abstract Ventures, NCBiotech, Artis Ventures, HHS
Tech stack
WordpressMysqlMariadbPhpVarnishYoast Seo
#9
Funding Raised · Raleigh, North Carolina · founded 2019$2.4Mraised▾
Funding Raised · Raleigh, North Carolina · founded 2019
Developer of gene therapy using AAV capsids and immune modulators. The company focuses on adapting natural mechanisms for safe, single-dose therapeutics. It researches human-tropic and antibody-evading AAV capsids. The company also develops single-chain immune modulators for therapeutic applications.
Funding rounds
- Mar 2025Grant (prize money)$328.1K
- Sep 2022Grant (prize money)$261.1K
- Sep 2021Grant (prize money)$328.1K
- Sep 2020Grant (prize money)$1.2M
Founders & team
Investors
HHS
#10
Seed · Raleigh, North Carolina · founded 2020 · 2 employees$1.4Mraised▾
Seed · Raleigh, North Carolina · founded 2020 · 2 employees
Developer of therapeutic solutions for the treatment of hematology disorders. The company is involved in the development of gene therapy-based solutions and drug candidates that help to deliver healthy genes to a variety of cell targets within the body. It provides solutions for treating liver-directed diseases such as hemophilia, lysosomal storage disorders, and inherited ocular diseases by using optimized codon, a strong liver promoter, and novel cleavage sequence technologies.
LinkedIn Pulse recent public activity · Jul 2026
Audience: 758 LinkedIn followers — 2.8% of this cohort's audience
Funding rounds
- May 2025Grant (prize money)$2.5M
- Mar 2025Grant (prize money)$2.5M
- Apr 2024Grant (prize money)$1.2M
- Aug 2022Seed$1.4M
Founders & team
Investors
NCBiotech, HHS
#11
Series D · Raleigh, North Carolina · founded 2005 · 33 employees$66Mraised▾
Series D · Raleigh, North Carolina · founded 2005 · 33 employees
Provider of vascular stenting with embolic protection for both coronary and peripheral vasculature. The company's product offering includes Corguard - coronary stent system with integrated embolic protection; Vanguard - peripheral dilation balloon with integrated embolic protection; Paladin - carotid post-dilation balloon with integrated embolic protection.
Funding rounds
- Apr 2023Series D$23M
- Apr 2022Series D$15.1M
- Jun 2020Series C—
- Jan 2020Series C$22.3M
Investors
Medtronic, Lightstone Ventures, Tidewater Investment Company, Amzak Health, NCBiotech, Hatteras Venture Partners
Tech stack
WordpressMysqlPhpWp EngineHstsCloudflare
#12
Seed · Raleigh, North Carolina · founded 2021 · 6 employees$127.5Kraised▾
Seed · Raleigh, North Carolina · founded 2021 · 6 employees
Developer of treatments for women health. The company aims to provide women with treatments for Postpartum Hemorrhage (PPH) and Abnormal Uterine Bleeding (AUB) that are accessible anywhere in the world.
LinkedIn Pulse recent public activity · Jul 2026
Audience: 395 LinkedIn followers
Funding rounds
- Sep 2025Seed$2.8M
- Nov 2022Seed$127.5K
Founders & team
Funding & investor landscape
$1.1Btotal disclosed funding
45companies funded
186disclosed rounds
0rounds last 90 days
Most active investors
Notable founders
Neil Buckley
Co-Founder & CEO · Slate Medicines
David Dworaczyk
Retired CEO: Corporate Advisor/Consultant to Bryn Pharma · Bryn Pharma
Yongmei Xu
Co-Founder · Glycan Therapeutics
Jian Liu
Co-Founder & Chief Scientific Officer · Glycan Therapeutics
John Fahy
Founder · Aer Therapeutics
Jim Shaffer
CEO · Aer Therapeutics
James Green
Chief Executive Officer · Vogenx
Paul Garofolo
Chief Executive Officer · Locus Biosciences
Bedrock Inc
Owner · Bedrock Therapeutics
Damon Race
CEO & President · GeneVentiv Therapeutics
Peter Pacult
Co-Founder & CEO · Avana Health
Alexander Richter
Co-Founder · Benanova
Prism market signals · United States · country-scoped Prism corpus, 1,465,538 docs
Market landscape — 10 sub-themes by coverage
Share of Life Sciences coverage by sub-theme.
Regulatory-risk over time rising
Funding & growth over time
funding rising · growth rising
RESEARCH SIGNALS · United States
How research on Biotechnology is moving in the United States
A read on the academic research around Biotechnology — which themes are gaining ground, the institutions and researchers driving them, and how the tone is shifting. Based on 6,260 United States-affiliated papers.
research sentiment over time
200820162026
enthusiastic · positive · guarded tone
Tone is overwhelmingly optimistic and steady — the enthusiastic (strongly-positive) share moved 44% → 42% across 2008–2026.
top research entities
- Harvard University209
- Cornell University177
- University of Tennessee at Chattanooga140
- Howard Hughes Medical Institute126
- Johns Hopkins University121
leading researchers
Stylianos Chatzimanolis · TARIK DEDOVIC · KATH-RYN ANN F. HANKINS · Christoforos Pavlou · Giannis Bolanakis · Ashley R Tetens · Tyler Findlay · Jordyn Craig-Schwartz
▲
Breakthroughs2,038 · 33%
▼ 41%→30% share
▼0.7× share momentum0 median citations71% since 2021mostly empirical
Gene-focused breakthrough research surged 5× (33→164 papers), cementing it as the dominant discovery sub-topic in U.S. biotech.
rising sub-themes (early→recent)
- Gene33→164
- Transcription (linguistics)11→79
- Antibody11→62
- Genome6→56
- Mutation7→56
Newly emergingIdentification (biology) 0→18 · Function (biology) 0→18 · Reporter gene 0→16
Landmark U1 snRNP regulates cancer cell migration and invasion in vitro · 7,224 cites
◆
Advancements2,118 · 34%
▲ 29%→35% share
▲1.2× share momentum0 median citations80% since 2021mostly empirical
Cell culture and gene expression advancements each jumped 3→62 papers, signaling intensifying applied translation of foundational biology.
rising sub-themes (early→recent)
- Gene8→110
- Cell culture3→62
- Gene expression3→62
- Fermentation2→54
- Downregulation and upregulation1→50
Newly emergingIdentification (biology) 0→27 · Probiotic 0→24 · Cultivar 0→23
Landmark Using Deep Learning for Image-Based Plant Disease Detection · 4,262 cites
▼
Concerns1,006 · 16%
▼ 17%→15% share
▼0.9× share momentum0 median citations73% since 2021mostly empirical
Antibiotic resistance concern papers tripled (15→45), while agriculture worries rose 3× (19→58), reflecting dual biosafety pressures.
rising sub-themes (early→recent)
- Agriculture19→58
- Antibiotic resistance15→45
- Public health4→31
- Gene6→30
- Production (economics)5→29
Newly emergingQuality (philosophy) 0→27 · Animal health 0→14 · Integrated pest management 0→13
Landmark The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate · 8,812 cites
RESEARCH HOTSPOTS · United States
Where biotechnology is researched across United States
Location clusters by institution affiliation — each city's volume, stance tone, and a quick read on its hot topic, what's advancing, the opening opportunity, and the main concern.
Boston351 · +0.52
New York319 · +0.47
SF Bay Area235 · +0.57
Philadelphia115 · +0.60
San Diego101 · +0.59
Seattle95 · +0.46
Chicago95 · +0.57
Los Angeles93 · +0.61
Pittsburgh65 · +0.54
Ann Arbor65 · +0.58
PATENT SIGNAL · United States
Who's filing biotechnology patents in the United States
United States biotechnology patent filing is accelerating — 457,918 filings from 8,000 assignees (2016–2025), led by Genentech, UNIV California, Regeneron Pharma; annual filings 36884→44446.
457,918 filings8,000 assigneespeak 51616/yr2016–2025
filing momentum (YoY 2016–2025)
top patent filers
- Genentech18078
- UNIV California17948
- Regeneron Pharma16082
- Amgen10495
- Monsanto Technology9742
- UNIV Pennsylvania8521
- Harvard College7460
- UNIV Texas7378
Common questions
How many Life Sciences companies are there in Raleigh, United States?
Radar tracks 87 indexable Life Sciences companies headquartered in Raleigh, United States that meet our profile-completeness bar.
What is the total funding raised by Life Sciences companies in Raleigh, United States?
The Life Sciences companies in Raleigh, United States on this list have raised a combined $1.1B in disclosed equity funding across 45 funded companies.
Which is the highest-funded Life Sciences company in Raleigh, United States?
Sprout Pharmaceuticals is the highest-funded Life Sciences company in Raleigh, United States, with $174.6M in disclosed equity funding.
How many Life Sciences companies in Raleigh, United States are funded?
45 of the 87 Life Sciences companies in Raleigh, United States on this list have disclosed at least one equity funding round.
How many Life Sciences unicorns are there in Raleigh, United States?
None of the Life Sciences companies in Raleigh, United States on this list currently has a disclosed valuation of $1B or more.
Who are the top investors in Raleigh, United States Life Sciences companies?
The most active investors in Raleigh, United States Life Sciences companies on this list include HHS, NCBiotech, National Science Foundation, America’s Seed Fund, Hatteras Venture Partners.
Rohit KhannaTrends & Stories
Rohit lives in the feed. He covers what's moving right now — the funding rounds, launches and shifts breaking across the trade press — and ties them back to where the sector is heading.